Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof

Applications:
Along with 1174, the present invention is directed to provide a chimeric protein capable of transduction into B cells for purposes of treating Class Switch Recombination and Somatic Hypermutation, both involved in antibody production and diversity, as well as other conditions such as B cell lymphoma.

URV Reference Number: 6-1202
Patent Information:
Category(s):
Therapeutic
For Information, Contact:
Matan Rapoport
Licensing Associate
University of Rochester
585.276.6600
matan.rapoport@rochester.edu
Inventors:
Harold Smith
Mark Sowden
Stephen Dewhurst
Baek Kim
Joseph Wedekind
Keywords:
Cancer
Gene Therapy
Oncology